NDC 0781-7238-06 - BUPRENORPHINE AND NALOXONE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0781-7238
Requested NDC
0781-7238-06
Package NDCs from labels
0781-7238-06, 0781-7238-64
Manufacturer
Indivior Inc.
Effective date
2021-04-19
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
BUPRENORPHINE AND NALOXONE - Indivior Inc.Indivior Inc.2021-04-19HUMAN PRESCRIPTION DRUG LABEL

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0781-7238-06EA - Each0781-7238d1b5f310-3461-4db8-baf5-71c631018dc912019-05-02
0781-7238-64EA - Each0781-7238600640b1-4c07-4200-97a8-c84d78c5925012019-03-12

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 15 · 286 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHenry Schein, Inc.ddeebc32-9aab-4a2f-8c87-74335d17d5ef2026-11-05Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEHenry Schein, Inc.d39635a4-ddb3-4d32-8211-eb84c78e9f592026-11-05Warnings, Adverse reactionsExact identifier
unii: F850569PQR
naloxone hydrochlorideNALOXONE HYDROCHLORIDEREMEDYREPACK INC.5b13a13f-6ec8-41eb-b216-e43ffd68f01e2026-11-02Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACID MONOHYDRATEPAI Holdings, LLC dba PAI Pharma63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd52026-10-30Adverse reactionsExact identifier
unii: 1Q73Q2JULR
pentazocine and naloxonePENTAZOCINE AND NALOXONESun Pharmaceutical Industries, Inc.41ebdaaf-3bbc-419f-b996-0341efc146232026-10-29Boxed warning, Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Buprenorphine hydrochlorideBUPRENORPHINE HYDROCHLORIDEGland Pharma Limited69ec3405-78ee-4cb4-9180-9bea937a8dcd2026-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
AQUACETIC-30CLEANING SOLUTION FOR HEMODIALYSIS MACHINESAqua Medica, S.A. de C.V.040775ab-41bd-cd36-e063-6394a90a08aa2026-10-16WarningsExact identifier
unii: 2968PHW8QP
CITRACID-50DESINFECTANT SOLUTION FOR HEMODIALYSIS MACHINEAqua Medica, S.A. de C.V.040713e7-67cd-8eb0-e063-6394a90aa2a92026-10-16WarningsExact identifier
unii: 2968PHW8QP
Naloxone HydrochlorideNALOXONE HYDROCHLORIDESomerset Therapeutics, LLCb59ee3cc-9604-4abc-81be-897e2f42aa672026-10-15Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Artificial TearsGLYCERINPreferred Pharmaceuticals Inc.dd646c72-8f47-43c6-a734-db0dcc8cd4d12026-10-14WarningsExact identifier
unii: 3NXW29V3WO
Sal De Uvas PicotCITRIC ACID MONOHYDRATE, SODIUM BICARBONATENavajo Manufacturing Company Inc.ff6ac79d-564d-4abf-83c7-b01751249c7f2026-10-09WarningsExact identifier
unii: 2968PHW8QP
Sal de Uvas PicotCITRIC ACID MONOHYDRATE AND SODIUM BICARBONATENavajo Manufacturing Company Inc.5d6d297d-770b-dd9f-e063-6294a90a4bb82026-10-02WarningsExact identifier
unii: 2968PHW8QP
REXTOVYNALOXONE HYDROCHLORIDEInternational Medication Systems, Ltd.fe9735db-c57e-44a8-bffb-b87a84c2a6f32026-09-30Warnings, Adverse reactionsExact identifier
unii: F850569PQR
buprenorphine hydrochloride and naloxone hydrochloride dihydrateBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATEGolden State Medical Supply, Inc.4f6e0056-b19d-0d0e-e063-6294a90a16e52026-09-21Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
buprenorphine hydrochlorideBUPRENORPHINE HYDROCHLORIDEREMEDYREPACK INC.9f7b0a28-f937-4d4d-b793-ca3468bd28e02026-09-17Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
BUPRENORPHINE AND NALOXONEBUPRENORPHINE AND NALOXONEMajor Pharmaceuticalsc5fbec69-e7de-44a8-b9fa-0378ae61a9fe2026-09-02Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEAmneal Pharmaceuticals LLC8091a73d-9ecd-4578-a57b-5d85a2c5a16a2026-08-25WarningsExact identifier
unii: F850569PQR
Rohto All-In-OneHYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATEThe Mentholatum Company43e690e4-b381-46e3-838c-33aef5bdadde2026-08-20WarningsExact identifier
unii: 3NXW29V3WO
buprenorphine hydrochloride and naloxone hydrochloride dihydrateBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATEREMEDYREPACK INC.4124c4ad-ef62-4c95-8e57-0d843862ae712026-08-17Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1
buprenorphine hydrochloride and naloxone hydrochloride dihydrateBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATEREMEDYREPACK INC.43027750-d218-49e5-867f-c941736d20562026-08-17Warnings, Adverse reactionsExact identifier
unii: 56W8MW3EN1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.